条件 PROTAC:调节向蛋白质降解的最新策略
Junhyeong Yim1,2, Junyoung Park1,3, Gabin Kim4
1Department of Chemistry, Kangwon National University, Chuncheon, 24341, Republic of Korea.
ChemMedChem
|July 12, 2024
概括
向蛋白解酶的仿真体 (PROTACs) 通过无素-蛋白酶体系统 (UPS) 提供有针对性的蛋白质降解. 本综述探讨了空间时间控制的化学策略,以提高PROTAC的疗效并最大限度地减少副作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白解酶的仿真体 (PROTACs) 使用无素-蛋白酶体系统 (UPS) 进行向蛋白质降解.
- 虽然PROTAC对无法药物治疗的目标有很大的希望,但它面临着组织外效应和副作用的挑战.
- 提高PROTAC的有效性需要精确的空间和时间控制策略.
研究的目的:
- 通过使用PROTACs审查化学策略,以实现细胞类型特定 (空间) 和时间特定 (时间) 的蛋白质降解.
- 为了解决当前针对性蛋白质降解策略的局限性提供见解.
- 突出空间-时间 PROTAC 在各种疾病背景中的潜力.
主要方法:
- 对空间时间 PROTAC 开发的化学策略的文献综述.
- 基于细胞位置和时间的PROTAC活动调节方法的分析.
- 综合当前关于提高PROTAC特异性和疗效的研究.
主要成果:
- 确定各种化学方法,使得 PROTAC 诱导的降解能够在空间和时间上得到控制.
- 展示时空调制如何减轻组织外影响并改善治疗窗口.
- 通过有针对性的降解策略,突出显示 PROTAC 技术的多功能性.
结论:
- 时空控制是PROTAC技术的一个关键进步.
- 精确降解的化学策略为克服当前PROTAC限制提供了一条途径.
- 具有增强特异性的向蛋白质降解具有显著的治疗潜力.
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Proteasome
827
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
827
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K


